For more information about any of our studies:
Sophie
773-702-9066
sboutouis@bsd.uchicago.edu
Madison
773-834-3778
mcollins4@bsd.uchicago.edu
Borderline Personality Disorder
“A Double-Blind, Placebo-Controlled Study of Caplyta in the Treatment of Borderline Personality Disorder.”
The purpose of this research is to gather information on the safety and effectiveness of Caplyta in adults with BPD.
For more information on this study: https://clinicaltrials.gov/study/
Sign up for this study: https://www.surveymonkey.com/r/BPDRecruitment
“An Open Label Study of Single-Dose Psilocybin for Major Depressive Disorder with co-occurring Borderline Personality Disorder”
By doing this study, we hope to learn if psilocybin helps in reducing the symptoms of MDD and co-occurring BPD.
For more information on this study: https://clinicaltrials.gov/study/
Obsessive Compulsive Disorder (OCD)
“A Double-Blind, Randomized, Placebo Controlled Study of Tolcapone for OCD”
The purpose of this research is to gather information on the safety and effectiveness of Tolcapone for the treatment of OCD in multiple doses.
For more information on this study: https://clinicaltrials.gov/study/
Sign up for this study: https://www.surveymonkey.com/r/H3V27H2
“A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Troriluzule in Obsessive Compulsive Disorder”
The primary objective of the study is to evaluate the efficacy, long term safety, and tolerability of troriluzule as adjunctive therapy in subjects with OCD who have had an inadequate response to SSRI, clomipramine, venlafaxine or desvenlafaxine treatment.
For more information on this study: https://clinicaltrials.gov/study/
Sign up for this study: https://www.surveymonkey.com/r/WV6RS78
“An Open-Label Trial of Epidiolex in the Treatment of Obsessive Compulsive Disorder and related disorders”
The primary objective of this 3-visit, open-label study is to evaluate the safety and efficacy of Epidiolex (cannabidiol) in adults with OCD, BFRBs, and hoarding disorder.
For more information on this study: https://clinicaltrials.gov/study/
Sign up for this study: https://www.surveymonkey.com/r/KGLFDDS
Body Focused Repetitive Behaviors : Trichotillomania + Dermatillomania
“Natural Recovery in BFRBs”
Overarching goal to characterize the clinical phenotypes of Body Focused Repetitive Behaviors (BFRBs) that are associated with natural recovery from their disorders.
Sign up for this study: https://www.surveymonkey.com/r/MX6ZNN2
https://www.surveymonkey.com/r/MYXSW2B
“Single-Group Crossover Trial Comparing Behavioral Treatment to Memantine in Body Focused Repetitive Behaviors”
The purpose of this study is to compare the efficacy of comprehensive behavioral treatment (ComB) to memantine, a psychopharmacological agent, for body focused repetitive behaviors (BFRBs).
For more information on this study: https://clinicaltrials.gov/study/
Sign up for this study: https://www.surveymonkey.com/r/BPTM56K
Mood Disorders
“A Study of Disease Characteristics and Real-life Standard of Care Effectiveness in Patients with Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including an SSRI or SNRI (Non-interventional)”
The purpose of this research study is to understand the social and demographic factors, disease-related and treatment-related characteristics, and standard of care (SOC) treatment patterns in participants with Major Depressive Disorder (MDD) with anhedonia (reduced ability to experience interest, motivation, enjoyment, or pleasure) who have had an inadequate response to their current antidepressant treatment, inclusive of SSRIs or SNRIs.
For more information on this study: https://clinicaltrials.gov/study/
“An Open Label Study of Single-Dose Psilocybin for Major Depressive Disorder with co-occurring Borderline Personality Disorder”
By doing this study, we hope to learn if psilocybin helps in reducing the symptoms of MDD and co-occurring BPD.
For more information on this study: https://clinicaltrials.gov/study/
Tourette’s Disorder
“A Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Maintenance of Efficacy of Ecopipam in Children, Adolescents and Adults with Tourette’s Disorder”
The purpose of this study is to learn about the safety and efficacy of Ecopipam as a possible treatment for TD compared with a placebo.
For more information on this study: https://clinicaltrials.gov/study/
Sign up for this study: https://www.surveymonkey.com/r/MV8TKWR
Substance Use Disorders
“Randomized, Placebo-Controlled Trial of Extended Release Naltrexone and Monthly Extended Release Buprenorphine for Cocaine Use Disorder (CURB-2)”
The purpose of this study is to see if combined treatment with injectable Vivitrol® (XR-NTX; extended-release naltrexone) and injectable Sublocade® (XR-BUP; extended-release buprenorphine) are safe and effective for helping people cut down or stop using cocaine.
For more information on this study: https://clinicaltrials.gov/study/
Sign up for this study: https://www.surveymonkey.com/r/TDXP5ST
“Combining Medication Assisted Treatment with Daily or Weekly Cognitive Processing Therapy for PTSD and Opioid Use Disorder: A Randomized Controlled Trial”
The purpose of this study is to evaluate whether medication assisted treatment using Suboxone and either daily or weekly Cognitive Processing Therapy (CPT) can be combined to manage opioid use disorder (OUD) and posttraumatic stress disorder (PTSD) symptoms.